Driving drug discovery and development for Metabolic conditions with clinico-genomics

Leveraging our geographically extensive network of health system partners across the US, Helix has built a rapidly growing clinico-genomic cohort of thousands of GLP-1 agonist treated patients:

• Linked Exome sequencing plus full EHR records from an ethnically diverse patient population 
• All of the lab measures included in the pivotal trials, such as HbA1c and blood glucose, matched with patient vitals and demographic information
• Access to the Helix Research Network database in the form of yearly data licenses and/or translational research collaborations